David Altshuler, geneticist who helped transform Vertex, to retire next year

David Altshuler, geneticist who helped transform Vertex, to retire next year

Since becoming Vertex's top scientist in 2015, Altshuler has helped the company become an industry powerhouse. He’ll depart next year in a “planned transition.”

Vertex Pharmaceuticals Chief Scientific Officer David Altshuler to Retire in 2024 After Nearly a Decade of Leadership

David Altshuler, who has served as Vertex Pharmaceutica […] The post Vertex Pharmaceuticals Chief Scientific Officer David Altshuler to Retire in 2024 After Nearly a Decade of Leadership first appeared on GeneOnline News. The post Vertex Pharmaceuticals Chief Scientific Officer David Altshuler to Retire in 2024 After Nearly a Decade of Leadership appeared first on GeneOnline News.

Vertex’s top scientist Altshuler to retire, next-generation pain drug fails

Vertex Pharmaceuticals’ longtime chief scientific officer David Altshuler plans to retire next year, the company announced as part of its second-quarter earnings. Vertex also reported major shakeups to its experimental pain programs.